CompletedNot Applicable

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

United States33 participantsStarted 2014-05-01

Plain-language summary

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Who can participate

Age range2 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study. Exclusion Criteria * None

What they're measuring

long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation

Timeframe: 5 years

Trial details

NCT IDNCT02039557

SponsorGamida Cell ltd

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-06-29

View on ClinicalTrials.gov More Patients Transplanted With NiCord/CordIn (Omidubicel) trials